Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 14 / Drugs : 16 - (DrugBank : 5) / Drug target genes : 7 - Drug target pathways : 16

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Brivaracetam
   UCB Pharma S.A.
      2006   -   EUCTR2006-000169-12-SE   Finland;France;Italy;Netherlands;Sweden
   UCB S.A.
      2006   Phase 3   EUCTR2006-001536-46-FR   Finland;France
      2006   Phase 3   EUCTR2006-001536-46-FI   Finland;France
      2006   -   EUCTR2006-000169-12-NL   Finland;France;Italy;Netherlands;Sweden
      2006   Phase 3   EUCTR2006-000169-12-FR   Finland;France;Italy;Netherlands;Sweden
      2006   -   EUCTR2006-000169-12-FI   Finland;France;Italy;Netherlands;Sweden
   UCB S.A. Casa Madre
      2007   -   EUCTR2006-000169-12-IT   Finland;France;Italy;Netherlands;Sweden
Brivaracetam 25 MG
   UCB Pharma SA
      2006   Phase 3   NCT00357669   Finland;France;Italy;Netherlands;Réunion;Sweden;Tunisia
Brivaracetam 50 MG
   UCB Pharma SA
      2006   Phase 3   NCT00357669   Finland;France;Italy;Netherlands;Réunion;Sweden;Tunisia
BRV 2.5 MG
   UCB Pharma
      2006   Phase 3   NCT00368251   Canada;Finland;Former Serbia and Montenegro;France;Israel;Russian Federation;Serbia;Tunisia;United States
BRV 25 MG
   UCB Pharma
      2006   Phase 3   NCT00368251   Canada;Finland;Former Serbia and Montenegro;France;Israel;Russian Federation;Serbia;Tunisia;United States
BRV 50 MG
   UCB Pharma
      2006   Phase 3   NCT00368251   Canada;Finland;Former Serbia and Montenegro;France;Israel;Russian Federation;Serbia;Tunisia;United States
Cetirizina
   AZIENDA USL DI BOLOGNA
      2023   Phase 2   EUCTR2023-000185-34-IT   Italy
Clervonafusp alfa
   AZIENDA USL DI BOLOGNA
      2023   Phase 2   EUCTR2023-000185-34-IT   Italy
Intravenous immunoglobulin
   Azienda Socio Sanitaria Territoriale di Mantova
      2015   Phase 3   NCT03351569   -
ION283
   Berge Minassian
      2024   Phase 1/Phase 2   NCT06609889   United States
J06ba02
   AZIENDA SOCIO SANITARIA TERRITORIALE DI MANTOVA
      -   Phase 3   EUCTR2017-002147-15-IT   Italy
Paracetamolo
   AZIENDA USL DI BOLOGNA
      2023   Phase 2   EUCTR2023-000185-34-IT   Italy
Requip
   Department of Neurology, Turku University Hospital
      2007   -   EUCTR2007-003210-33-FI   Finland
Ropinirole hydrochloride
   Department of Neurology, Turku University Hospital
      2007   -   EUCTR2007-003210-33-FI   Finland
UCB 34714
   UCB Pharma S.A.
      2006   -   EUCTR2006-000169-12-SE   Finland;France;Italy;Netherlands;Sweden
   UCB S.A.
      2006   Phase 3   EUCTR2006-001536-46-FR   Finland;France
      2006   Phase 3   EUCTR2006-001536-46-FI   Finland;France
      2006   -   EUCTR2006-000169-12-NL   Finland;France;Italy;Netherlands;Sweden
      2006   Phase 3   EUCTR2006-000169-12-FR   Finland;France;Italy;Netherlands;Sweden
      2006   -   EUCTR2006-000169-12-FI   Finland;France;Italy;Netherlands;Sweden
VAL-1221
   AZIENDA USL DI BOLOGNA
      2023   Phase 2   EUCTR2023-000185-34-IT   Italy